On Tuesday, Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) was 0.97% up from the session before settling in for the closing price of $21.75. A 52-week range for CPRX has been $12.27 – $22.27.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 4106.79%. When this article was written, the company’s average yearly earnings per share was at 74.29%. With a float of $102.43 million, this company’s outstanding shares have now reached $107.12 million.
Let’s determine the extent of company efficiency that accounts for 167 employees. In terms of profitability, gross margin is 82.44%, operating margin of 19.77%, and the pretax margin is 21.53%.
Catalyst Pharmaceuticals Inc (CPRX) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Catalyst Pharmaceuticals Inc stocks. The insider ownership of Catalyst Pharmaceuticals Inc is 13.70%, while institutional ownership is 75.42%. The most recent insider transaction that took place on Aug 21 ’24, was worth 301,455. In this transaction Director of this company sold 15,000 shares at a rate of $20.10, taking the stock ownership to the 348,874 shares. Before that another transaction happened on Aug 20 ’24, when Company’s Chief Op. & Scientific Officer sold 150,000 for $20.35, making the entire transaction worth $3,052,900. This insider now owns 675,124 shares in total.
Catalyst Pharmaceuticals Inc (CPRX) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 6/30/2024, it has been observed that the corporation posted -0.29 earnings per share (EPS) during the time that was less than consensus figure (set at -0.28) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.28 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 74.29% per share during the next fiscal year.
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Trading Performance Indicators
You can see what Catalyst Pharmaceuticals Inc (CPRX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.00. Likewise, its price to free cash flow for the trailing twelve months is 16.24.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.53, a number that is poised to hit 0.30 in the next quarter and is forecasted to reach 1.39 in one year’s time.
Technical Analysis of Catalyst Pharmaceuticals Inc (CPRX)
Looking closely at Catalyst Pharmaceuticals Inc (NASDAQ: CPRX), its last 5-days average volume was 0.81 million, which is a drop from its year-to-date volume of 1.19 million. As of the previous 9 days, the stock’s Stochastic %D was 68.55%. Additionally, its Average True Range was 0.59.
During the past 100 days, Catalyst Pharmaceuticals Inc’s (CPRX) raw stochastic average was set at 95.88%, which indicates a significant increase from 78.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 18.38% in the past 14 days, which was lower than the 34.77% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $20.56, while its 200-day Moving Average is $17.09. However, in the short run, Catalyst Pharmaceuticals Inc’s stock first resistance to watch stands at $22.20. Second resistance stands at $22.45. The third major resistance level sits at $22.84. If the price goes on to break the first support level at $21.56, it is likely to go to the next support level at $21.17. Should the price break the second support level, the third support level stands at $20.92.
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Key Stats
There are 118,688K outstanding shares of the company, which has a market capitalization of 2.61 billion. As of now, sales total 398,200 K while income totals 71,410 K. Its latest quarter income was 122,710 K while its last quarter net income were 40,790 K.
